AXIM Biotechnologies, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $-4.8M | $47.3K |
| FY2023 | — | $-7.7M | $156.5K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $-4.8M | $47.3K |
| FY2023 | — | $-7.7M | $156.5K |